The medical profession grudgingly admits (some still deny it) that SSRI antidepressants raise suicide risk in adolescents, but claims they pose no such risk in adults. They’re wrong – SSRI and the newer SSNRI drugs do indeed increase suicidal behaviour in adults. Drug companies have done all they can to hide this, but here’s the evidence that gives up their sleazy game.
In Part 1, I shared with you the story of ‘Adriano’, who went through hell after taking the SSRI antidepressant fluvoxamine. As you are about to learn, Adriano is hardly the only individual who experienced frightening personality changes after taking this supposedly ‘safe’ drug. Numerous medical papers have documented fluvoxamine-induced aggression, mania, violence and suicide. Fluvoxamine was also involved in the most famous school shooting of all time.
I haven’t written much about anti-depressant drugs over the years. The reason is simple: They were of little interest to me. However, I recently witnessed someone I know closely go through pure hell on a SSRI drug known as fluvoxamine. The changes in his outlook and behaviour while on fluvoxamine were truly alarming – he began morphing into a different person. After witnessing his frightening ordeal, I promptly began scrutinizing the research on anti-depressants, especially the widely prescribed variants known as Selective Serotonin Reuptake Inhibitors (SSRIs). What I uncovered truly shocked me.
When independent researchers recently reanalyzed the results of a trial involving the widely-used anti-depressant paroxetine (Paxil), they uncovered some very disturbing results.